Neurocrine lays off sales force

By Elaine Rigoli

Tampa, Fla., July 26 - Neurocrine Biosciences, Inc. said it has laid off the entire Neurocrine field sales organization and will incur a one-time charge of about $5.9 million relating to termination of the sales force, eliminating ongoing 2006 sales-force expenses by about $16 million.

"We have always been proud of our commitment to our employees and their families and are disappointed that events have led us to take these steps. Despite our best efforts, we have not been successful in acquiring a product which our sales force could promote," president and chief executive officer Gary Lyons said in a statement.

Neurocrine is a biopharmaceutical company based in San Diego.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.